Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.3' was added to the record history; the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' entry were removed from the page.
    Difference
    0.2%
    Check dated 2025-12-20T19:37:14.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2; this is a minor maintenance update with no impact on study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-29T02:06:39.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 was added to the record history, and revision v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-21T22:59:37.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    A notice about government funding and potential update delays at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-14T15:40:38.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Version 2 (2022-10-17) updated the Study Status. Version 3 (2024-04-23) updated the Recruitment Status.
    Difference
    0.1%
    Check dated 2025-10-30T11:18:29.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.2 to v3.2.0; this signals a new release but does not modify core content, pricing, or key entities.
    Difference
    0.3%
    Check dated 2025-10-01T03:13:04.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.